Cancer Fund
Impact investorActively deployingPhoenix · Seed–Series C · 9 people tracked
Investment thesis
Cancer Fund backs early-stage oncology companies, focusing on pre-clinical and early-clinical innovations primarily at the Seed through Series A stages. It invests through Cancer Fund I, LLC, a 10-year fund term vehicle open to verified accredited investors, and complements this with a venture-giving donor-advised fund allowing anyone to support cancer innovation. The firm emphasizes patient capital at the earliest stages to fund proof points that unlock later development, and is supported by a 10,000+ community of physicians, scientists, survivors, and impact investors who help evaluate and follow the companies it funds across diagnostics, therapeutics, and remote monitoring.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website
What they invest in
from 3 of 9 portfolio companiesMedical Devices ×3AI & Machine Learning ×2Biotech ×2Healthtech ×2Deep Tech ×1Digital Health ×1Hardware ×1SaaS ×1
HQs:United States×3
Investments · 9 tracked
founders shown can be your intro path
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inAbigail Mcelhinny(Executive Officer)Oriana Zoghbi-Harb(Executive Officer, Director)
BoardSurbhi Sarna(Director)
Bladder cancer diagnostics (Series Seed-1)
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
NearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications.
AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesSaaSAustin, US
Roy Stillwell(Founder)in
Pan-cancer remote monitoring (Seed)
Therapeutics targeting glioblastoma (Series A)
HER2 breast cancer therapeutics (Seed 2A)
Frequently asked questions
- What stage does Cancer Fund invest at?
- Cancer Fund invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Cancer Fund focus on?
- Cancer Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Cancer Fund located?
- Cancer Fund is headquartered in Phoenix, US.
Images
Similar investors
Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
MDI Ventures is the corporate venture capital arm of Indonesia's Telkom Group, investing in technology startups and emphasizing measurable social and environmental impact alongside financial returns.
Asabys Partners is a healthcare and life sciences venture capital firm that invests in innovative science and medical technologies to improve patients' lives.